To see the other types of publications on this topic, follow the link: Gauchers disease.

Books on the topic 'Gauchers disease'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 40 books for your research on the topic 'Gauchers disease.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

Wendy, Schubert, and National Institutes of Health (U.S.). Clinical Center, eds. Understanding Gaucher disease. [Bethesda, Md.?]: Clinical Center, U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

National Institutes of Health (U.S.). Office of Clinical Center Communications, ed. Understanding Gaucher disease. [Bethesda, Md.?]: Clinical Center Communications, National Institutes of Health, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Kari, Carol. Understanding Gaucher disease. [Bethesda, Md.?]: Clinical Center, U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Grabowski, Gregory A. Gaucher Disease: Basic and Clinical Perspectives. Unitec House, 2 Albert Place, London N3 1QB, UK: Future Medicine Ltd, 2013. http://dx.doi.org/10.2217/9781780842011.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Kari, Carol. Gaucher's disease: A nurse's handbook : Clinical Center. [Bethesda, Md.?]: U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, Office of Clinical Reports and Inquiries, Clinical Center, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

National Institutes of Health (U.S.). Office of Clinical Reports and Inquiries, ed. Gaucher's disease: A nurse's handbook : Clinical Center. Bethesda, Md.?]: U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, Office of Clinical Reports and Inquiries, Clinical Center, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

M, Garber Alan, and United States. Congress. Office of Technology Assessment., eds. Federal and private roles in the development and provision of alglucerase therapy for Gaucher disease. Washington, DC: Office of Technology Assessment, 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

A, Grabowski Gregory, and Gardiner-Caldwell SynerMed, eds. A clinician's guide to Gaucher disease: A treatment algorithm. Califon, N.J: Gardiner-Caldwell SynerMed, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Karen, Bellenir, ed. Genetic disorders sourcebook: Basic information about heritable diseases and disorders such as Down syndrome, PKU, hemophilia, Von Willebrand disease, Gaucher disease, Tay-Sachs disease, and sickle cell disease ... Detroit, MI: Omnigraphics, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Bryant, Jackie. Ceredase in the treatment of Type 1 Gaucher's disease. Bristol: R&D Directorate, NHS Executive South and West, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
11

Beratan, Marian E. Gaucher disease: January 1984 through January 1995, plus selected earlier citations : 594 citations. Bethesda, Md. (8600 Rockville Pike): U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, National Library of Medicine, Reference Section, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
12

National Institutes of Health (U.S.), ed. Gaucher disease: Current issues in diagnosis and treatment : National Institutes of Health Technology Assessment Conference statement, February 27-March 1, 1995. Bethesda, MD: NIH Office of Medical Applications of Research, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
13

National Institutes of Health Technology Assessment Conference (1995 Bethesda, Md.). NIH Technology Assessment Conference on Gaucher Disease: Current issues in diagnosis and treatment : February 27-March 1, 1995 : [program and abstracts]. [Bethesda, Md: National Institutes of Health, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
14

Surprised to be standing: A spiritual journey. [United States]: Healing Light, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
15

National Institutes of Health Technology Assessment Conference (1995 Bethesda, Md.). NIH Technology Assessment Conference on Gaucher Disease: Current Issues in Diagnosis and Treatment : NIH Technology Assessment Conference, February 27-March 1, 1995, Warren Grant Magnuson Clinical Center, Masur Auditorium, National Institutes of Health, Bethesda, Maryland. [Bethesda, Md: The Institutes, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
16

Parker, James N., and Philip M. Parker. Gaucher disease: A bibliography and dictionary for physicians, patients, and genome researchers [to internet references]. San Diego, CA: ICON Health Publications, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
17

Parker, James N., and Philip M. Parker. Type 1 gaucher disease: A bibliography and dictionary for physicians, patients, and genome researchers [to internet references]. San Diego, CA: ICON Health Publications, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
18

Parker, James N., and Philip M. Parker. Type 3 gaucher disease: A bibliography and dictionary for physicians, patients, and genome researchers [to internet references]. San Diego, CA: ICON Health Publications, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
19

Parker, James N., and Philip M. Parker. Type 2 gaucher disease: A bibliography and dictionary for physicians, patients, and genome researchers [to internet references]. San Diego, CA: ICON Health Publications, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
20

Gaucher disease. Boca Raton: CRC/Taylor & Francis, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
21

Futerman, Anthony H., and Ari Zimran. Gaucher Disease. Taylor & Francis Group, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
22

Futerman, Anthony H., and Ari Zimran. Gaucher Disease. Taylor & Francis Group, 2019.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
23

Futerman, Anthony H., Anthony H. Futreman, and Ari Zimran. Gaucher Disease. Taylor & Francis Group, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
24

Futerman, Anthony H., and Ari Zimran. Gaucher Disease. Taylor & Francis Group, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
25

Gaucher disease. Boca Raton, FL: CRC/Taylor & Francis, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
26

Hollak, Carla E. M. Gaucher Disease. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199972135.003.0047.

Full text
Abstract:
Gaucher disease is frequently diagnosed in adulthood and may manifest at any age. Chronic neuronopathic forms are rarely seen but may come to the attention of the adult physician. Nonneuronopathic or type 1 disease is extremely variable. Main symptoms are cytopenia, hepatosplenomegaly and bone disease. The majority of patients diagnosed in adulthood present with thrombocytopenia and splenomegaly. In moderate to severe disease, treatment with intravenous enzyme replacement is highly effective. Substrate reduction therapy with miglustat or eliglustat is an oral alternative for some. Awareness of a number of severe complications and associated conditions, including irreversible bone disease, rare cancers and Parkinson's disease, is of importance.
APA, Harvard, Vancouver, ISO, and other styles
27

Gaucher Disease. CRC, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
28

Provan, Drew, Trevor Baglin, Inderjeet Dokal, and Johannes de Vos. Rare diseases. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199683307.003.0018.

Full text
APA, Harvard, Vancouver, ISO, and other styles
29

Bennett, Lunawati L. Gaucher's Disease: From Diagnosis to Treatment. Nova Science Publishers, Incorporated, 2020.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
30

Bennett, Lunawati L. Gaucher's Disease: From Diagnosis to Treatment. Nova Science Publishers, Incorporated, 2020.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
31

Zimran Gaucher's Disease - Haematology V10 No 4. Bailliere Tindall, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
32

Michels, Virginia V. Genetics. Oxford University Press, 2012. http://dx.doi.org/10.1093/med/9780199755691.003.0276.

Full text
Abstract:
Genetic factors play a role in the development of many types of human disease. Genetic determinants may be chromosome abnormalities (Down syndrome, Kleinfelter syndrome, Turner syndrome), single gene defects (dilated and hypertrophic cardiomyopathies, Ehlers-Danlos syndrome, Marfan syndrome, neurofibromatosis, tuberous sclerosis, Gaucher disease, cystic fibrosis, sickle cell disease), mitochondrial mutations (MELAS, MERRF, Kearns-Sayre syndrome), or epigenetic or multifactorial factors. Genetics testing methods are also reviewed.
APA, Harvard, Vancouver, ISO, and other styles
33

Hollak, Carla E. M. Skeletal Abnormalities. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199972135.003.0072.

Full text
Abstract:
The skeleton is frequently involved in inborn error of metabolism as part of a chronic, multisystem disease. Several disorders in adulthood may present with skeletal symptoms as a first sign of an underlying metabolic disease. Examples are Gaucher disease, alkaptonuria, hypofosfatasia or hereditary hypophosphatemic rickets. In addition, secondary skeletal problems, specifically osteoporosis, is a frequent complication of a wide range of inborn errors of metabolism. The presence of additional symptoms, specific radiographical appearance and/or biochemical abnormalities can assist in making the appropriate diagnosis.
APA, Harvard, Vancouver, ISO, and other styles
34

Publications, ICON Health. Gaucher Disease - A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References. ICON Health Publications, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
35

Steensma, David P. Benign Hematology. Oxford University Press, 2012. http://dx.doi.org/10.1093/med/9780199755691.003.0294.

Full text
Abstract:
The major forms of benign hematologic conditions are anemia, neutropenia, transfusion reactions, Gaucher disease, and porphyria. Anemia is a sign of disease rather than a disease itself. Anemia results from 1 or more of 3 pathologic mechanisms: inadequate production of red blood cells (RBCs) by the bone marrow, blood loss, or premature destruction of RBCs. The major causes of neutropenia include hematologic neoplasm, metastatic neoplasm involving the marrow, irradiation, vitamin B12 deficiency and folate deficiency, drugs, infections, congenital or acquired primary disorders of hematopoiesis, autoimmune neutropenia, hypersplenism, hemodilution, and benign idiopathic neutropenia. The porphyrias are enzyme disorders that are autosomal dominant with low disease penetrance, except for congenital erythropoietic porphyria, which is autosomal recessive, and porphyria cutanea tarda, which may be acquired and is associated with hepatitis C and hemochromatosis.
APA, Harvard, Vancouver, ISO, and other styles
36

Publications, ICON Health. The Official Parent's Sourcebook on Gaucher's Disease: A Revised and Updated Directory for the Internet Age. Icon Health Publications, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
37

Minorry, Karol Yurry. Causes of Spleen Pain: Trauma,Splenic Abscess,Blood Flow Disorders,Viral Infections,Malaria,Sickle Cell Disease,Gaucher Disease,Liver Cirrhosis,Spleen Cancer,Leukemia. Independently Published, 2021.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
38

News, PM Medical Health. 21st Century Complete Medical Guide to Gaucher¿s Disease, Authoritative Government Documents, Clinical References, and Practical Information for Patients and Physicians (CD-ROM). Progressive Management, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
39

Karatasakis, G., and G. D. Athanassopoulos. Cardiomyopathies. Oxford University Press, 2011. http://dx.doi.org/10.1093/med/9780199599639.003.0019.

Full text
Abstract:
Echocardiography is a key diagnostic method in the management of patients with cardiomyopathies.The main echocardiographic findings of hypertrophic cardiomyopathy are asymmetric hypertrophy of the septum, increased echogenicity of the myocardium, systolic anterior motion, turbulent left ventricular (LV) outflow tract blood flow, intracavitary gradient of dynamic nature, mid-systolic closure of the aortic valve and mitral regurgitation. The degree of hypertrophy and the magnitude of the obstruction have prognostic meaning. Echocardiography plays a fundamental role not only in diagnostic process, but also in management of patients, prognostic stratification, and evaluation of therapeutic intervention effects.In idiopathic dilated cardiomyopathy, echocardiography reveals dilation and impaired contraction of the LV or both ventricles. The biplane Simpson’s method incorporates much of the shape of the LV in calculation of volume; currently, three-dimensional echocardiography accurately evaluates LV volumes. Deformation parameters might be used for detection of early ventricular involvement. Stress echocardiography using dobutamine or dipyridamole may contribute to risk stratification, evaluating contractile reserve and left anterior descending flow reserve. LV dyssynchrony assessment is challenging and in patients with biventricular pacing already applied, optimization of atrio-interventricular delays should be done. Specific characteristics of right ventricular dysplasia and isolated LV non-compaction can be recognized, resulting in an increasing frequency of their prevalence. Rare forms of cardiomyopathy related with neuromuscular disorders can be studied at an earlier stage of ventricular involvement.Restrictive and infiltrative cardiomyopathies are characterized by an increase in ventricular stiffness with ensuing diastolic dysfunction and heart failure. A variety of entities may produce this pathological disturbance with amyloidosis being the most prevalent. Storage diseases (Fabry, Gaucher, Hurler) are currently treatable and early detection of ventricular involvement is of paramount importance for successful treatment. Traditional differentiation between constrictive pericarditis (surgically manageable) and the rare cases of restrictive cardiomyopathy should be properly performed.
APA, Harvard, Vancouver, ISO, and other styles
40

Osteoporosis sourcebook: Basic consumer health information about primary and secondary osteoporosis and juvenile osteoporosis and related conditions, including fibrous dysplasia, Gaucher disease, hyperthyroidism, hypophosphatasia, myeloma, osteopetrosis, osteogenesis imperfecta, and Paget's disease ; along with information about risk factors, treatments, traditional and nontraditional pain management, a glossary of related terms , and a directory of resources. Detroit, MI: Omnigraphics, 2001.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography